We are live on ! Find out more
HS

HighVista Strategies Portfolio holdings

AUM $362M
1-Year Est. Return 230.96%
This Fund
S&P 500
This Quarter Est. Return
+5.41%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$141M
AUM Growth
+$6.43M
Cap. Flow
+$9.56M
Cap. Flow %
6.78%
Top 10 Hldgs %
55.72%
Holding
161
New
36
Increased
33
Reduced
7
Closed
45

Top Buys

Rank Stock Value
1
GRUB
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
+$8.56M
2
INFO
IHS Markit Ltd. Common Shares
INFO
+$3.47M
3
NUAN
Nuance Communications, Inc.
NUAN
+$3.42M
4
CPARU
Catalyst Partners Acquisition Corp. Unit
CPARU
+$2.01M
5
ATHM icon
Autohome
ATHM
+$1.32M

Top Sells

Rank Stock Value
1
IPHI
INPHI CORPORATION
IPHI
+$3.84M
2
RP
RealPage, Inc.
RP
+$3.37M
3
INDA icon
iShares MSCI India ETF
INDA
+$2.29M
4
GNW icon
Genworth Financial
GNW
+$1.92M
5
BABA icon
Alibaba
BABA
+$1.79M

Sector Composition

Rank Sector Weight
1 Technology 32.85%
2 Healthcare 32.22%
3 Financials 6.7%
4 Communication Services 6.68%
5 Consumer Discretionary 4.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NVTA
26
DELISTED
Invitae Corporation
NVTA
$906K 0.64%
26,870
+10,831
+68% +$352K
KYMR icon
27
Kymera Therapeutics
KYMR
$8.91B
$901K 0.64%
18,587
+4,646
+33% +$202K
ZYME icon
28
Zymeworks
ZYME
$1.7B
$883K 0.63%
25,452
+4,450
+21% +$141K
ARGX icon
29
argenx
ARGX
$55.2B
$879K 0.62%
2,919
+562
+24% +$160K
SWTX
30
DELISTED
SpringWorks Therapeutics
SWTX
$876K 0.62%
10,631
+962
+10% +$73K
OCUL icon
31
Ocular Therapeutix
OCUL
$2B
$875K 0.62%
+61,639
New +$937K
IGMS
32
DELISTED
IGM Biosciences
IGMS
$872K 0.62%
10,481
+1,560
+17% +$116K
BIDU icon
33
Baidu
BIDU
$36.9B
$858K 0.61%
4,207
-559
-12% -$112K
RLAY icon
34
Relay Therapeutics
RLAY
$4.42B
$851K 0.6%
23,250
+6,374
+38% +$210K
IOVA icon
35
Iovance Biotherapeutics
IOVA
$2.89B
$845K 0.6%
32,458
+14,295
+79% +$372K
CCCC icon
36
C4 Therapeutics
CCCC
$410M
$822K 0.58%
21,729
+4,142
+24% +$148K
SNDX icon
37
Syndax Pharmaceuticals
SNDX
$1.8B
$821K 0.58%
47,814
+12,941
+37% +$237K
DBC icon
38
Invesco DB Commodity Index Tracking Fund
DBC
$1.7B
$816K 0.58%
42,396
– –
RCKT icon
39
Rocket Pharmaceuticals
RCKT
$399M
$816K 0.58%
18,424
+4,088
+29% +$178K
OLMA icon
40
Olema Pharmaceuticals
OLMA
$1.04B
$815K 0.58%
29,122
+14,667
+101% +$417K
MRSN
41
DELISTED
Mersana Therapeutics
MRSN
$814K 0.58%
+2,396
New +$907K
FOLD
42
DELISTED
Amicus Therapeutics
FOLD
$813K 0.58%
+84,371
New +$824K
HZNP
43
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$813K 0.58%
8,679
+91
+1% +$8.37K
PMVP icon
44
PMV Pharmaceuticals
PMVP
$63.5M
$812K 0.58%
23,758
+2,880
+14% +$96.2K
AVIR icon
45
Atea Pharmaceuticals
AVIR
$406M
$801K 0.57%
+37,295
New +$1.12M
KURA icon
46
Kura Oncology
KURA
$848M
$801K 0.57%
38,428
+8,216
+27% +$204K
TIL icon
47
Instil Bio
TIL
$49.3M
$801K 0.57%
+2,072
New +$768K
SPRY icon
48
ARS Pharmaceuticals
SPRY
$588M
$800K 0.57%
25,906
+11,839
+84% +$380K
ASND icon
49
Ascendis Pharma A/S
ASND
$16.7B
$797K 0.57%
6,060
+555
+10% +$74K
BBIO icon
50
BridgeBio Pharma
BBIO
$16.7B
$796K 0.56%
+13,056
New +$746K
1
2
3 4 5

Similar funds

SIAG
Safeguard Investment Advisory Group Corona, California $362M AUM 20.96% 1-Year Est. Return
MS
Millington Securities Red Bank, New Jersey $362M AUM
WI
WBI Investments Red Bank, New Jersey $362M AUM 23.75% 1-Year Est. Return
WTFG
Wood Tarver Financial Group Boise, Idaho $362M AUM 14.75% 1-Year Est. Return
RC
Reik & Co New York $363M AUM 3.03% 1-Year Est. Return
VIA
Virtus Investment Advisers Hartford, Connecticut $363M AUM 34.89% 1-Year Est. Return
A6
Anchor @ 65 Singapore $362M AUM 20.02% 1-Year Est. Return
PI
Pennant Investors Summit, New Jersey $361M AUM 134.26% 1-Year Est. Return

HighVista Strategies's Q2 2021 Portfolio in Review

As of Q2 2021, HighVista Strategies held 161 positions worth $141M, up 4.8% from $135M the previous quarter. Its ten largest holdings account for 56% of the portfolio.

HighVista Strategies deployed $9.56M of net new capital in Q2 2021, opening 36 new positions and adding to 33 existing holdings. Its largest new stake was IHS Markit Ltd. Common Shares: 32,743 shares worth $3.69M.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Alibaba, an estimated $1.79M trimmed.

  • HighVista Strategies's largest Q2 2021 buy was IHS Markit Ltd. Common Shares: 32,743 shares worth $3.69M.
  • HighVista Strategies added most to Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, an estimated $8.56M increase.
  • HighVista Strategies's biggest Q2 2021 reduction was Alibaba, cutting an estimated $1.79M.
  • HighVista Strategies fully exited INPHI CORPORATION in Q2 2021, selling an estimated $3.84M.
  • HighVista Strategies's ten largest holdings make up 56% of its $141M portfolio in Q2 2021.
  • HighVista Strategies opened 36 new positions and closed 45 in Q2 2021.
  • HighVista Strategies's portfolio value rose 4.8% quarter-over-quarter to $141M.

Based on HighVista Strategies's 13F filing for Q2 2021, filed 16 Aug 2021.